Well Lead Medical Co., Ltd. (603309.SS)
CNY 11.52
(2.31%)
CNY 11.52
(2.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 319.61 Million CNY | 1.2% |
| 2022 | 285.14 Million CNY | 37.66% |
| 2021 | 204.55 Million CNY | -18.25% |
| 2020 | 250.78 Million CNY | 20.18% |
| 2019 | 206.96 Million CNY | 114.46% |
| 2018 | 105.76 Million CNY | 1.96% |
| 2017 | 97.32 Million CNY | -13.67% |
| 2016 | 114.6 Million CNY | -2.75% |
| 2015 | 118.77 Million CNY | 10.59% |
| 2014 | 105.38 Million CNY | 17.93% |
| 2013 | 91.28 Million CNY | 9.39% |
| 2012 | 79.43 Million CNY | 37.52% |
| 2011 | 60.7 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 70.58 Million CNY | -21.74% |
| 2024 Q1 | 66.44 Million CNY | 3.59% |
| 2024 Q2 | 82.73 Million CNY | 7.53% |
| 2023 Q3 | 55.53 Million CNY | 1.6% |
| 2023 Q2 | 54.65 Million CNY | -24.86% |
| 2023 FY | - CNY | 1.2% |
| 2023 Q1 | 72.73 Million CNY | 66.58% |
| 2023 Q4 | 73.01 Million CNY | 31.49% |
| 2022 FY | - CNY | 37.66% |
| 2022 Q3 | 72.97 Million CNY | 22.22% |
| 2022 Q2 | 59.7 Million CNY | 13.26% |
| 2022 Q1 | 52.72 Million CNY | 20.71% |
| 2022 Q4 | 43.66 Million CNY | -40.16% |
| 2021 Q4 | 43.67 Million CNY | -5.0% |
| 2021 Q1 | 32.49 Million CNY | 62.82% |
| 2021 FY | - CNY | -18.25% |
| 2021 Q2 | 34.1 Million CNY | 4.94% |
| 2021 Q3 | 45.97 Million CNY | 34.81% |
| 2020 Q4 | 19.95 Million CNY | -65.53% |
| 2020 Q2 | 120.24 Million CNY | 696.11% |
| 2020 Q1 | 15.1 Million CNY | -61.52% |
| 2020 FY | - CNY | 20.18% |
| 2020 Q3 | 57.89 Million CNY | -51.85% |
| 2019 Q2 | 63.3 Million CNY | 145.73% |
| 2019 FY | - CNY | 114.46% |
| 2019 Q1 | 25.76 Million CNY | 13.86% |
| 2019 Q4 | 39.25 Million CNY | -16.39% |
| 2019 Q3 | 46.94 Million CNY | -25.84% |
| 2018 Q2 | 20.59 Million CNY | 129.92% |
| 2018 Q3 | 20.47 Million CNY | -0.62% |
| 2018 Q4 | 22.62 Million CNY | 10.53% |
| 2018 FY | - CNY | 1.96% |
| 2018 Q1 | 8.95 Million CNY | -54.59% |
| 2017 FY | - CNY | -13.67% |
| 2017 Q4 | 19.72 Million CNY | 23.31% |
| 2017 Q3 | 15.99 Million CNY | -42.31% |
| 2017 Q1 | 14.55 Million CNY | -66.68% |
| 2017 Q2 | 27.73 Million CNY | 90.6% |
| 2016 Q1 | 13.22 Million CNY | -68.44% |
| 2016 Q4 | 43.67 Million CNY | 97.3% |
| 2016 FY | - CNY | -2.75% |
| 2016 Q3 | 22.13 Million CNY | -19.29% |
| 2016 Q2 | 27.42 Million CNY | 107.4% |
| 2015 Q3 | 26.42 Million CNY | -5.2% |
| 2015 Q1 | 14.25 Million CNY | -19.36% |
| 2015 FY | - CNY | 10.59% |
| 2015 Q4 | 41.89 Million CNY | 58.52% |
| 2015 Q2 | 27.87 Million CNY | 95.55% |
| 2014 Q2 | 28.76 Million CNY | 62.79% |
| 2014 Q4 | 17.68 Million CNY | -37.82% |
| 2014 Q1 | 17.66 Million CNY | 0.0% |
| 2014 FY | - CNY | 17.93% |
| 2014 Q3 | 28.43 Million CNY | -1.13% |
| 2013 FY | - CNY | 9.39% |
| 2012 FY | - CNY | 37.52% |
| 2011 FY | - CNY | 0.0% |